Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 5 of 37
Newsletters
Pfizer CEO Albert Bourla acknowledges the innate difficulty of defeating COVID
By
Bernhard Warner
and
Alan Murray
April 13, 2022
Finance
Pfizer’s new CFO is a former CVS Health finance chief—and will oversee more than numbers
By
Sheryl Estrada
April 11, 2022
Health
Second COVID-19 booster shots protect against Omicron infections—but not for long, major study says
By
Ian Mount
April 6, 2022
Newsletters
‘None of these scenarios is good for the business.’ Inside Ikea’s decision to withdraw from Russia
By
Bernhard Warner
and
Alan Murray
April 6, 2022
Newsletters
The 5 forces that will transform business over the next decade
By
Bernhard Warner
and
Alan Murray
April 4, 2022
Newsletters
Is it time to rethink CEO pay for companies receiving billions in state aid and subsidies?
By
Bernhard Warner
and
Alan Murray
April 1, 2022
Success
How Moderna kept its mostly millennial staff from burning out while developing the COVID vaccine
By
Jane Thier
March 31, 2022
Health
Omicron has all but wiped out the more deadly Delta strain—but that’s not necessarily a good thing
By
Christiaan Hetzner
March 31, 2022
Newsletters
Business leaders challenge fellow CEOs to raise their game on net-zero commitments
By
Bernhard Warner
and
Alan Murray
March 31, 2022
Health
FDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By
Lauran Neergaard
,
Matthew Perrone
and
The Associated Press
March 29, 2022
Newsletters
The pandemic has accelerated innovation across industries—particularly in health care
By
Bernhard Warner
and
Alan Murray
March 28, 2022
Health
Pfizer shares slide after it recalls blood pressure drug over cancer-risk fears
By
Sophie Mellor
March 23, 2022
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By
Andrew Marquardt
March 15, 2022
Health
China just locked down 50 million people amid ‘stealth Omicron’ fears. The former FDA head predicts what happens next
By
Marco Quiroz-Gutierrez
March 15, 2022
International
Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients
By
Riley Griffin
and
Bloomberg
March 14, 2022
Most Popular
Personal Finance
Trump turns government into giant debt collector with threat to garnish wages on millions of Americans in default on...
By
Annie Ma
and
The Associated Press
Real Estate
Mark Zuckerberg gifted noise-canceling headphones to his Palo Alto neighbors because of the nonstop construction around...
By
Dave Smith
Retail
Trump just declared Christmas Eve a national holiday. Here’s what’s open and closed
By
Dave Smith